Narasimha Venkata Lakshmi, Butner J L, Hanafi Enjeline, Farokhnia Mehdi, Bhad Roshan, Chalabianloo Fatemeh, Kouimtsidis Christos, Baldacchino Alexander, Arunogiri Shalini
Assistant Professor, Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Deoghar, Jharkhand, India.
Addiction Medicine Specialist, Yale University School of Medicine, New Haven, Connecticut, USA.
BJPsych Int. 2022 Aug;19(3):66-69. doi: 10.1192/bji.2022.1.
The COVID-19 pandemic has significantly affected treatment services for people with substance use disorders (SUDs). Based on the perspectives of service providers from eight countries, we discuss the impact of the pandemic on SUD treatment services. Although many countries quickly adapted in provision of harm reduction services by changes in policy and service delivery, some went into a forced abstinence-based strategy. Similarly, disruption of abstinence-based approaches such as therapeutic communities has been reported. Global awareness is crucial for responsible management of SUDs during the pandemic, and the development of international health policy guidelines is an urgent need in this area.
新冠疫情对物质使用障碍(SUDs)患者的治疗服务产生了重大影响。基于来自八个国家的服务提供者的观点,我们讨论了疫情对SUD治疗服务的影响。尽管许多国家通过政策和服务提供方式的改变迅速调整了减少伤害服务的提供,但有些国家采取了基于强制戒断的策略。同样,也有报道称基于戒断的方法(如治疗社区)受到了干扰。在疫情期间,全球意识对于负责任地管理SUDs至关重要,制定国际卫生政策指南是这一领域的迫切需求。